Japanese Products Can Find A Home In Emerging Markets With Partners Like Roche
This article was originally published in PharmAsia News
Executive Summary
Roche plans to sign China-exclusive in-licensing deals with two Japanese pharma by the end of the year. The head-start of Roche and other western pharma has given them the capability and appetite for larger portfolios in key Asian markets.